View ValuationEcomembrane 향후 성장Future 기준 점검 3/6Ecomembrane은 연간 수입과 매출이 각각 14.5%와 17.7% 증가할 것으로 예상되고 EPS는 연간 16.2%만큼 증가할 것으로 예상됩니다.핵심 정보14.5%이익 성장률16.23%EPS 성장률Machinery 이익 성장19.8%매출 성장률17.7%향후 자기자본이익률n/a애널리스트 커버리지Low마지막 업데이트17 Apr 2026최근 향후 성장 업데이트Price Target Changed • Apr 13Price target decreased by 8.5% to €6.50Down from €7.10, the current price target is provided by 1 analyst. New target price is 31% above last closing price of €4.96. Stock is up 36% over the past year.모든 업데이트 보기Recent updatesBuy Or Sell Opportunity • May 05Now 20% undervaluedOver the last 90 days, the stock has risen 3.5% to €5.05. The fair value is estimated to be €6.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 18% per annum. Earnings are also forecast to grow by 15% per annum over the same time period.Upcoming Dividend • May 04Inaugural dividend of €0.096 per shareEligible shareholders must have bought the stock before 11 May 2026. Payment date: 13 May 2026. This is the first dividend for Ecomembrane since going public. The average dividend yield among industry peers is 1.0%.Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €5.65, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 14x in the Machinery industry in Italy. Total returns to shareholders of 38% over the past year.New Risk • Apr 17New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). High level of non-cash earnings (21% accrual ratio). Minor Risk Market cap is less than US$100m (€21.5m market cap, or US$25.3m).Price Target Changed • Apr 13Price target decreased by 8.5% to €6.50Down from €7.10, the current price target is provided by 1 analyst. New target price is 31% above last closing price of €4.96. Stock is up 36% over the past year.Reported Earnings • Apr 08Full year 2025 earnings releasedFull year 2025 results: Revenue: €26.3m (up 30% from FY 2024). Net income: €1.14m (up €975.5k from FY 2024). Profit margin: 4.3% (up from 0.8% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the Machinery industry in Italy.공지 • Apr 06Ecomembrane S.p.A., Annual General Meeting, Apr 21, 2026Ecomembrane S.p.A., Annual General Meeting, Apr 21, 2026, at 17:15 W. Europe Standard Time.공지 • Mar 24Ecomembrane S.p.A. announces Annual dividend, payable on May 13, 2026Ecomembrane S.p.A. announced Annual dividend of EUR 0.0960 per share payable on May 13, 2026, ex-date on May 11, 2026 and record date on May 12, 2026.New Risk • Mar 19New major risk - Revenue and earnings growthEarnings have declined by 84% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 84% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€21.0m market cap, or US$24.2m).New Risk • Feb 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€18.0m market cap, or US$21.3m).공지 • Feb 03+ 1 more updateEcomembrane S.p.A. to Report First Half, 2026 Results on Sep 25, 2026Ecomembrane S.p.A. announced that they will report first half, 2026 results on Sep 25, 2026분석 기사 • Oct 01Is Ecomembrane (BIT:ECMB) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Buy Or Sell Opportunity • Apr 15Now 27% overvaluedOver the last 90 days, the stock has fallen 15% to €3.90. The fair value is estimated to be €3.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 21% per annum. Earnings are also forecast to grow by 53% per annum over the same time period.New Risk • Apr 02New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 236% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.8% net profit margin). Market cap is less than US$100m (€16.7m market cap, or US$18.2m).공지 • Jan 27+ 1 more updateEcomembrane S.p.A. to Report Fiscal Year 2024 Results on Mar 14, 2025Ecomembrane S.p.A. announced that they will report fiscal year 2024 results on Mar 14, 2025공지 • Oct 14BayWa r.e. bioenergy GmbH completed the acquisition of 37.8932% stake in Alvus S.r.l and Favus S.r.l.- Favus Gmbhfrom from Ecomembrane S.r.l.BayWa r.e. bioenergy GmbH signed an agreement to acquire a 18.9466% stake in Alvus S.r.l and Favus S.R.L. - Favus Gmbh from Ecomembrane S.r.l. on August 9, 2023. The agreement, in addition to providing a set of declarations and guarantees, provides for the occurrence of certain conditions precedent before the closing, expected by the end 2023. BayWa r.e. bioenergy GmbH completed the acquisition of 18.9466% stake in Alvus S.r.l and Favus S.R.L. - Favus Gmbh from Ecomembrane S.r.l. on October 12, 2023.New Risk • Aug 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 4.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (4.7% average weekly change). Market cap is less than US$100m (€33.3m market cap, or US$36.2m).이익 및 매출 성장 예측BIT:ECMB - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202848223112/31/202745212112/31/202641101112/31/2025261-1-1N/A9/30/202524101N/A6/30/202523023N/A3/31/202521012N/A12/31/202420011N/A9/30/2024190-10N/A6/30/2024170-2-1N/A3/31/2024161-20N/A12/31/2023151-30N/A12/31/202215212N/A12/31/2021121N/AN/AN/A더 보기애널리스트 향후 성장 전망수입 대 저축률: ECMB 의 연간 예상 수익 증가율(14.5%)이 saving rate(3.3%)보다 높습니다.수익 vs 시장: ECMB 의 연간 수익(14.5%)이 Italian 시장(10.3%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: ECMB 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: ECMB 의 수익(연간 17.7%)이 Italian 시장(연간 5.9%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: ECMB 의 수익(연간 17.7%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: ECMB의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.성장 기업 찾아보기7D1Y7D1Y7D1YCapital-goods 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/07 03:25종가2026/05/07 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Ecomembrane S.p.A.는 3명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Luigi De BellisEquita SIM S.p.A.Roberto LetiziaEquita SIM S.p.A.Domenico GhilottiEquita SIM S.p.A.
Price Target Changed • Apr 13Price target decreased by 8.5% to €6.50Down from €7.10, the current price target is provided by 1 analyst. New target price is 31% above last closing price of €4.96. Stock is up 36% over the past year.
Buy Or Sell Opportunity • May 05Now 20% undervaluedOver the last 90 days, the stock has risen 3.5% to €5.05. The fair value is estimated to be €6.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 18% per annum. Earnings are also forecast to grow by 15% per annum over the same time period.
Upcoming Dividend • May 04Inaugural dividend of €0.096 per shareEligible shareholders must have bought the stock before 11 May 2026. Payment date: 13 May 2026. This is the first dividend for Ecomembrane since going public. The average dividend yield among industry peers is 1.0%.
Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €5.65, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 14x in the Machinery industry in Italy. Total returns to shareholders of 38% over the past year.
New Risk • Apr 17New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). High level of non-cash earnings (21% accrual ratio). Minor Risk Market cap is less than US$100m (€21.5m market cap, or US$25.3m).
Price Target Changed • Apr 13Price target decreased by 8.5% to €6.50Down from €7.10, the current price target is provided by 1 analyst. New target price is 31% above last closing price of €4.96. Stock is up 36% over the past year.
Reported Earnings • Apr 08Full year 2025 earnings releasedFull year 2025 results: Revenue: €26.3m (up 30% from FY 2024). Net income: €1.14m (up €975.5k from FY 2024). Profit margin: 4.3% (up from 0.8% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the Machinery industry in Italy.
공지 • Apr 06Ecomembrane S.p.A., Annual General Meeting, Apr 21, 2026Ecomembrane S.p.A., Annual General Meeting, Apr 21, 2026, at 17:15 W. Europe Standard Time.
공지 • Mar 24Ecomembrane S.p.A. announces Annual dividend, payable on May 13, 2026Ecomembrane S.p.A. announced Annual dividend of EUR 0.0960 per share payable on May 13, 2026, ex-date on May 11, 2026 and record date on May 12, 2026.
New Risk • Mar 19New major risk - Revenue and earnings growthEarnings have declined by 84% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 84% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€21.0m market cap, or US$24.2m).
New Risk • Feb 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€18.0m market cap, or US$21.3m).
공지 • Feb 03+ 1 more updateEcomembrane S.p.A. to Report First Half, 2026 Results on Sep 25, 2026Ecomembrane S.p.A. announced that they will report first half, 2026 results on Sep 25, 2026
분석 기사 • Oct 01Is Ecomembrane (BIT:ECMB) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Buy Or Sell Opportunity • Apr 15Now 27% overvaluedOver the last 90 days, the stock has fallen 15% to €3.90. The fair value is estimated to be €3.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 21% per annum. Earnings are also forecast to grow by 53% per annum over the same time period.
New Risk • Apr 02New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 236% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.8% net profit margin). Market cap is less than US$100m (€16.7m market cap, or US$18.2m).
공지 • Jan 27+ 1 more updateEcomembrane S.p.A. to Report Fiscal Year 2024 Results on Mar 14, 2025Ecomembrane S.p.A. announced that they will report fiscal year 2024 results on Mar 14, 2025
공지 • Oct 14BayWa r.e. bioenergy GmbH completed the acquisition of 37.8932% stake in Alvus S.r.l and Favus S.r.l.- Favus Gmbhfrom from Ecomembrane S.r.l.BayWa r.e. bioenergy GmbH signed an agreement to acquire a 18.9466% stake in Alvus S.r.l and Favus S.R.L. - Favus Gmbh from Ecomembrane S.r.l. on August 9, 2023. The agreement, in addition to providing a set of declarations and guarantees, provides for the occurrence of certain conditions precedent before the closing, expected by the end 2023. BayWa r.e. bioenergy GmbH completed the acquisition of 18.9466% stake in Alvus S.r.l and Favus S.R.L. - Favus Gmbh from Ecomembrane S.r.l. on October 12, 2023.
New Risk • Aug 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 4.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (4.7% average weekly change). Market cap is less than US$100m (€33.3m market cap, or US$36.2m).